Using Technology to Share Fitness Goals and Results to Improve Diabetes Outcomes

NCT ID: NCT02761018

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-08-08

Study Completion Date

2018-10-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators will recruit DoD beneficiaries, aged 18 years or older and diagnosed as being Type II diabetic. Patients will be randomized into one of two groups. Group 1 will use a fitness tracker but will not be able to see other participants data and group 2 will use a fitness tracker and will be able to see other members daily and weekly results. Outcome measures will be assessed at baseline, 3 months and 6 months to include hemoglobin A1c, weight, body mass index, blood pressure, and number of hours and days fitness tracker is used. The goal is to see if the group randomized into an online community will have improved activity and outcome measurements compared with those who use the pedometer alone.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Male and female DoD beneficiaries ages 18 years or older who have been diagnosed with Type II diabetes, will be recruited at the Mike O'Callaghan Federal Medical Center (MOFMC).

Screening Visit:

* Obtain signed Informed Consent Document and HIPAA Authorization (research-driven).
* Record: Date of birth, phone number, age, gender, race, ethnicity, social security number, current email address, height (in inches), weight (in pounds), blood pressure, medications list including any over-the-counter and prescription weight loss medication (name, strength, dose) or supplements.
* Subjects will have the following standard of care blood test drawn which include:

* Hemoglobin A1c via 1 venipuncture (5-10 mls, approximately 1-2 teaspoons of blood will be drawn)

Visit 1 (Day 1 within 1 week of Screening Visit):

* Record: Weight (in pounds), blood pressure, and any changes to their medications list.
* Subjects will complete the RAND 36 Item Health Survey.
* Subjects will complete the Intake Questionnaire.
* Subjects will be assigned their Fitness Tracker username and their username and password will be recorded by the Research Coordinator.
* Subjects will be given User Instructions based off of their randomization group.
* Subjects will be instructed to follow all research procedures and that failure to do so may result in the removal from the study and the return of the Fitness Tracker.
* Subjects will be randomized by the research coordinator using a random-number generator into one of two groups (research-driven):

* Group 1: will use a fitness tracker but will not be able to see other participant's data.
* Group 2: will use a fitness tracker and will be able to see other member's daily and weekly results.

* Both groups will receive the scripted feedback at set time intervals by the Research Coordinators.
* Subjects will be provided a fitness tracker and instructed on how to use it.

* If subject is a DoD beneficiary, and finishes all study-related procedures at month 6, they will keep the fitness tracker. If a subject does not complete all study-related procedures, they will be asked to return the fitness tracker so the investigators can erase their data and re-issue to another study subject.
* If subject is active duty or a DoD employee, regardless of their study completion, they will be asked to complete Temporary Issue Receipt and bring back the fitness tracker at the end of the study.

Visit 2 (Month 3/90 days post Visit 1):

* Record: Weight (in pounds), blood pressure and any changes to their medications list.
* Subjects will complete the RAND 36 Item Health Survey.
* Subjects will complete the Follow up Questionnaire.
* Obtain information from their fitness tracker.
* Subjects will have the following standard of care blood test drawn which include:

* Hemoglobin A1c via 1 venipuncture (5-10 mls, approximately 1-2 teaspoons of blood will be drawn)

Final Visit 3 (Month 6/90 days post Visit 2):

* Record: Weight (in pounds), blood pressure and any changes to their medications list.
* Subjects will complete the RAND 36 Item Health Survey and be asked some additional questions.
* Subjects will complete the Follow up Questionnaire.
* Obtain information from their fitness tracker.
* Subjects will have the following standard of care blood test drawn which include:

* Hemoglobin A1c via 1 venipuncture (5-10 mls, approximately 1-2 teaspoons of blood will be drawn)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type II Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fitness Tracker

will use a fitness tracker but will not be able to see other participant's data

Group Type EXPERIMENTAL

Fitness Tracker

Intervention Type BEHAVIORAL

will use a fitness tracker and will be able to see other member's daily and weekly results

Fitness Tracker with Group Participation

will use a fitness tracker and will be able to see other member's daily and weekly results

Group Type EXPERIMENTAL

Behavioral: Fitness Tracker

Intervention Type BEHAVIORAL

will use a fitness tracker but will not be able to see other participant's data

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Behavioral: Fitness Tracker

will use a fitness tracker but will not be able to see other participant's data

Intervention Type BEHAVIORAL

Fitness Tracker

will use a fitness tracker and will be able to see other member's daily and weekly results

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female DoD beneficiaries, age 18 years or older, who have been diagnosed with Type II Diabetes
* Ability to set up fitness tracking software on personal computer or cell phone
* Ability to learn and use personal activity monitor

Exclusion:

* Male and female DoD beneficiaries, under the age of 18 years
* Unwilling to share personal fitness results anonymously
* Inability to do 4 metabolic equivalents of exercise (walk 100feet, walk up flight of stairs etc).
* Inability to walk without the use of assistive devices (cane is OK)
* Medical problem which would make walking unsafe (recent surgery, uncontrolled heart condition, fall risk etc).
* No special populations (e.g., pregnant women, children, prisoners, detainees) will be recruited.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mike O'Callaghan Military Hospital

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

David Carlsen, MD

Role: PRINCIPAL_INVESTIGATOR

Principal Investigator

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mike O'Callaghan Federal Medical Center

Nellis Air Force Base, Nevada, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FWH20160062H

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

HOPE Intervention for Fitness
NCT07114822 RECRUITING NA